Liver Diseases  >>  oprozomib (ONX 0912)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oprozomib (ONX 0912) / Amgen
NCT02227914: Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma

Withdrawn
1b/2
0
US
Oprozomib, Sorafenib
Amgen
Advanced Hepatocellular Carcinoma
03/15
03/15

Download Options